🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To determine the efficacy of SAR441344 as measured by r...
Status
Active Not Recruiting
Location
Center for Neurology and Spine- Site Number : 8400007
Start Date
2021-06-07
Trial ID
NCT04879628
Treatments Being Tested
This is a randomized, open-label, parallel, Phase 3 study with 2-arms for t...
Status
Recruiting
Location
North Central Neurology Associates- Site Number : 8401100
Start Date
2026-01-14
Trial ID
NCT07325292
Treatments Being Tested
The purpose of each study is to independently measure the annualized relaps...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401135
Start Date
2023-12-13
Trial ID
NCT06141473
This is a multinational, randomized, placebo-controlled, parallel treatment...
Status
Active Not Recruiting
Location
Accel Research Sites Network - Birmingham- Site Number : 8400003
Start Date
2021-11-10
Trial ID
NCT05039840
Treatments Being Tested
This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment o...
Status
Recruiting
Location
Investigational Site Number : 8400007
Start Date
2024-12-19
Trial ID
NCT06500702
Treatments Being Tested
The purpose of this randomized, double-blind, placebo-controlled, parallel ...
Status
Active Not Recruiting
Location
Alabama Neurology Associates- Site Number : 8400115
Start Date
2023-12-27
Trial ID
NCT06141486
Treatments Being Tested
This is a randomized, parallel group, double-blind Phase 2 study with a bli...
Status
Active Not Recruiting
Location
University of California San Francisco - Mission Bay- Site Number : 8400012
Start Date
2023-12-11
Trial ID
NCT06111586
Treatments Being Tested
The purpose of this open-label, randomized, active-comparator-controlled st...
Status
Recruiting
Location
Brigham & Women's Hospital- Site Number : 8400049
Start Date
2026-03-13
Trial ID
NCT07412470